CollPlant Biotechnologies (CLGN) Times Interest Earned (2017 - 2025)
CollPlant Biotechnologies' (CLGN) quarterly Times Interest Earned came in at -$0.11 in Q4 2025, up 97.97% YoY from -$0.06 in Q4 2024, and up 97.97% on a QoQ basis from -$5.37 in Q4 2024.
CollPlant Biotechnologies (CLGN) Times Interest Earned (2017 - 2025) Analysis & Trends
CollPlant Biotechnologies (CLGN) has 9 years of Times Interest Earned data on file, last reported at -$0.11 in Q4 2025.
- Quarterly Times Interest Earned rose 97.97% year-over-year to -$0.11 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$0.18 (down 162.84% YoY) and the FY2025 annual result came in at -$0.4, up 47.44% from the prior year.
- Times Interest Earned grew to -$0.11 in Q4 2025, from -$5.37 in the prior quarter.
- In the past five years, Times Interest Earned ranged from a high of $382.88 in Q2 2021 to a low of -$527.68 in Q1 2021.
- A 5-year average of $8.11 and a median of $6.43 in 2023 frame the typical range for Times Interest Earned.
- Annual changes were most pronounced in 2021 — Times Interest Earned slumped 223.65% — and 2023, when it surged 54209.73%.
- Tracing CLGN's Times Interest Earned over 5 years: stood at -$0.11 in 2021, then sank by 95.34% to -$0.21 in 2022, then surged by 54209.73% to $112.62 in 2023, then sank by 104.77% to -$5.37 in 2024, then surged by 97.97% to -$0.11 in 2025.
- The last three Times Interest Earned figures came in at -$0.11 (Q4 2025), -$5.37 (Q4 2024), and $98.74 (Q3 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.42 |
| 10 | CollPlant Biotechnologies | 4.26 Mn | 4.26 Mn | -243,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -0.11 |
| Dec 31, 2024 | -5.37 |
| Sep 30, 2024 | 98.74 |
| Jun 30, 2024 | 13.15 |
| Mar 31, 2024 | 34.63 |
| Dec 31, 2023 | 112.62 |
| Sep 30, 2023 | -40.73 |
| Jun 30, 2023 | 32.82 |
| Mar 31, 2023 | 12.48 |
| Dec 31, 2022 | -0.21 |
| Dec 31, 2021 | -0.11 |
| Sep 30, 2021 | 0.39 |
| Jun 30, 2021 | 382.88 |
| Mar 31, 2021 | -527.68 |
| Dec 31, 2020 | -0.70 |
| Sep 30, 2020 | -66.73 |
| Jun 30, 2020 | -956.50 |
| Mar 31, 2020 | 426.75 |
| Dec 31, 2019 | -1.91 |
| Sep 30, 2019 | 1.26 |